TrialJournal of neuro-oncology2013

A molecular biology and phase II trial of lapatinib in children with refractory CNS malignancies: a pediatric brain tumor consortium study.

Maryam Fouladi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.